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AUGMENTATION OF 
PULMONARY BLOOD 
FLOW WITH AN 
AXILLARY ARTERIOVENOUS 
FISTULA AFTER A 
CAVOPULMONARY SHUNT 
Of 320 children with cyanotic congenital heart malformations who had 
previously undergone cavopulmonary shunt operations, 11 had increasing 
cyanosis and exercise intolerance and were considered unsuitable for 
definitive repair, a Fontan procedure, or other pafiiation. Eight had a 
previous Glenn shunt and three had a previous bidirectional cavopulmo- 
nary connection. To augment pulmonary blood flow, 10 patients underwent 
creation of an ipsilateral axillary arteriovenous fistula. Mean oxygen 
saturations were 80% -- 2% before operation, 85% -- 2% immediately after 
operation, and 84% -- 3% at a mean follow-up interval of 7.4 years (range 
0.1 to 15.5 years). Mean hemoglobin values were 202 +- 10 gm/L before 
operation, 177 -- 10 gm/L after operation, and 191 - 14 gm/L at latest 
review. The only complication was mild swelling of the arm distal to the 
fistula in one patient. All patients reported improvement in exercise 
tolerance. Eight patients have continued evidence of fistula patency. 
Development of ipsilateral pulmonary arteriovenous fistulas has not been 
observed in any patient. Creation of an axillary arteriovenous fistula to 
augment pulmonary blood flow after a cavopulmonary shunt provides 
useful palliation for complex cyanotic heart disease when other options are 
limited. Such additional sources of pulmonary blood flow may influence the 
development of pulmonary arteriovenous fistulas. (J THORAC CARDIOVASC 
SURG 1996;111:176-80) 
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E xperimental bypass of the right side of the heart was initially performed by Carlon, Mondini, 
and de Marchi I in 1951. Further animal studies 
were performed by Glenn, 2 and in 1958 he re- 
ported the first clinical application of this concept, 
with a superior vena cava-right pulmonary artery 
end-to-end anastomosis bypassing the heart. 
Widely applied as palliation for a number of 
complex cardiac lesions not amenable to biven- 
tricular repair, the Glenn shunt has not remained 
the sole palliative treatment; for example, many 
lesions are now treatable with the more extended 
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total caval shunt proposed by Fontan and Bau- 
det)  More recently, an end-to-side superior vena 
cava-right pulmonary artery anastomosis (bidirec- 
tional cavopulmonary connection) has become a 
component of various treatment algorithms, al- 
lowing bilateral pulmonary flow, avoiding isola- 
tion of the right pulmonary artery, 4and acting as 
a preparatory step toward a Fontan procedure. 5 In 
some patients, who have undergone previous 
Glenn or bidirectional cavopulmonary anastomo- 
ses, the immediate surgical mortality rate associ- 
ated with definitive biventricular epair or cre- 
ation of an atrium-dependent circulation is 
unacceptably high. In such situations, it is possible 
to manage increasing cyanosis by creation or 
revision of a systemic arterial shunt. Alternatively, 
pulmonary blood ftow through the existing cavo- 
pulmonary shunt could be supplemented by cre- 
ation of an axillary arteriovenous (AV) fistula, a 
concept first proposed by Glenn and Fenn 6 in 
1972. In this report, we review our experience with 
the creation of an axillary AV fistula in a subgroup 
of patients who had previously undergone a 
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Table I. Patient clinical profiles 
Age at 
Pt. CPS Type of Age at fistula 
no. Sex Diagnosis (yr) CPS cmation (yr) 
1 F DIRV, AVSD, TGA, PS 4 Glenn 9 
2 F TA 8 Glenn 20 
3 M TA, PA 2 Glenn 19 
4 F TGA, PA, straddling TV 6 Glenn 15 
5 M DILV, TGA, PA, straddling TV 1 Glenn 20 
6 M TA, PS 7 Glenn 14 
7 M DILV, TGA, PA 5 Glenn 10 
8 F DORV (SPVSD), PS 2 Glenn - -  
9 M TOF, AVSD 2 BCPS 7 
l0 F TA 5 BCPS 11 
11 M DORV, PS 1 BCPS 4 
CPS, Cavopulmonary shunt; DIRV, double-inlet right ventricle;AVSD, atriove~tricular septal defect; TGA, transposition of the great arteries; PS, pulmonary 
stenosis; TA, tricuspid atresia; PA, pulmonary atresia; TV,, tricuspid valve; DILV,, double inlet left ventrMe; DORV, double outlet right ventricle; SPVSD, 
subpulmonary ventricular septal defect; TOF, tetralogy of Fallot; BCPS, bidirectional cavopulmonary shunt. 
cavopu lmonary  shunt and for whom other  treat- 
ment  opt ions were l imited. 
Methods 
Patient population. Between 1961 and January 1994, 
320 cavopulmonary shunts were performed at the Hospi- 
tal for Sick Children, Toronto, for palliation of cyanosis 
associated with complex heart lesions. Despite adequate 
early palliation with the caval shunt, 7 11 patients had 
progressive cyanosis and were considered poor candidates 
for definitive repair or a Fontan procedure. The underly- 
ing cardiac les~ons are listed in Table I. The first eight 
patients had undergone previous Glenn shunts (end-to- 
end anastomosis of the Superior vena ¢ava to the right 
pulmonary artery), and the remainder had undergone 
bidirectiona~ cavopulmonary shunts (end-to-side anasto- 
mosis of the superior vena cava to the right pulmonary 
artery). There were six male and five female patients; ages 
ranged from 4 to 20 years (median 12.5 years) and time 
from cavopulmonary shunt ranged from 3 to 185 years 
(median 6.4 years). Preoperative catheterization was per- 
formed in al! patients, and one patient (number 8) was not 
operated on because of multiple pulmonary AV fistulas in 
the shunted lung, whieh were a cause of the progressive 
eyanosis. The remainder (n = 10) underwent creation of 
an axillary AV fistula between June 1978 and January 
1994. One patient (number 2) was considered unsuitable 
for Fontan-type repair because of pulmonary vascular 
disease in the left lung after a Potts shunt. Five patients 
were considered unsuitable for further corrective repair 
because of ~nadequate l ft pulmonary artery size, three 
because of ~ previous Potts shunt (numbers 4, 6, and 7), 
one because of a left Blalock-Taussig shunt (number 3), 
and one because the native left pulmonary artery was 
hypoplastic (number 5). Patients 1 and 9 had atrioventric- 
ular valve regurgitation, and patient 9 also had poor 
ventricular function. In patients 10 and 11, a Fontan 
procedure had been performed hut required takedown 
after 3 mon~hs because of a hypoplastic left pulmonary 
artery, and after 2 weeks because of poor ventricular 
function, respectively. 
Procedure. The operative technique used was initially 
described by Glenn but modified by Trusler and cowork- 
ers. 8 With the patient under general anesthesia, an inci- 
sion is made 1 cm below and parallel to the lateral half of 
the clavicle; if necessary, it is extended along the course of 
the deltopectoral groove. The pectoralis major muscle is 
split in the direction of its fibers. The neurovascular 
bundle is identified, and the axillary artery and vein are 
isolated (Fig. 1). After systemic anticoagulation with 150 
U/kg body weight heparin sulfate, a vascular clamp is
placed across the artery and vein. A side-to-side anasto- 
mosis, 6 to 7 mm in iength, is made using a 5-0 or 6-0 
Prolene suture (Ethicón, Inc., Someville, N.J.). The axil- 
lary rein is ligated distal to the fistula to create a func- 
tional side-to-end AV anastomosis, Postoperative antico- 
agulation therapy is not given. 
Results 
All procedures were accomplished uneventfully. 
The only complication was mild swelling of the arm 
distal to the fistula in the first patient in whom the 
distal vein was not ligated; she required reoperat ion 
after 19 days. After the operation, all patients had 
improvement  of symptoms and increased exercise 
tolerance. On regular review, symptoms have been 
seen to be stable in all but three patients (numbers 
1, 3, and 5), who had deterioration from New York 
Heart  Association functional ciass 1 or 2 to class 3 or 
4 after 14, 10, or 7 years. All patients have been seen 
during the past year, and the mean duration of 
follow-up has been 7.4 years (range 0.1 to 15.5 
years). At the time of latest follow-up, all but two 
shunts (numbers 2 and 3) were patent. In patient 2, 
no murmur  has been present since 1990 (12 years 
after the procedure),  and a recent cardiac catheter- 
ization (1993) revealed that the fistula had occluded. 
Despite this occlusion, the patient's condition re- 
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Fig. 1. Diagram of operative technique used in creation of xillary AV fistulas. 
mains stable, with flow through the preexisting 
Glenn shunt and some contribution to pulmonary 
blood flow to the contralateral lung through a 
central shunt. In patient 3, cardiac atheterization in 
1991 revealed no flow in the fistula (12 years after 
procedure), and cardiac transplantation was at- 
tempted because of deteriorating cardiac clinical 
status. Unfortunately, transplantation was unsuc- 
cessful because of the presence of dense chest wall 
collateral vessels. 
Oxygen saturation and hemoglobin values imme- 
diately before operation, after operation, and at 
latest follow-up are shown in Fig. 2. The mean 
oxygen saturation values were 80% _+ 2% before 
operation, 85% _+ 2% after operation, and 84% _+ 
3 % at latest fol!ow-u p. The mean hemoglobin values 
were 202 + 10 gm/L before operation, 177 + 10 
gm/L after operation, and 191 _+ 14 gm/L at latest 
follow-up. Latest saturation results are skewed by 
deterioration i  patient 3, who had evidence of 
fistula occlusion as mentioned previously. 
Clinical evidence of cardiac failure has not been 
detected in any patient. Among those with follow-up 
longer than 1 year (n = 8), the absence of pulmo- 
nary AV fistulas has been documented in seven by 
angiography, and in the other no change in arterial 
saturation value has occurred. 
Discuss ion  
Data from this 7 and other institutions reveal that 
6 to 8 years after a cavopulmonary shunt the signs 
and symptoms of hypoxemia usually reappear. Pos- 
sible causes for the resurgence of cyanosis include 
the development of collateral venous channels be- 
tween superior and inferior venae cavae, reduction 
of blood flow to the contralateral lung, development 
of pulmonary AV fistulas in the ipsilateral lung, and 
possibly competitive flow to the upper lobes of the 
shunted lung by ingrowth of systemic ollateral 
vessels. The effects of these factors, alone or in 
combination, are compounded by the increase in 
blood viscosity caused by increasing hematocrit. 
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Fig. 2. A, Oxygen saturations (02Sat) before and after operation and at latest follow-up. B, Hemoglobin 
(Hgb) values before and after operation and at latestfollow-up. 
When a fistulous communication is created, there 
are increases in effective pulmonary blood flow and 
systemic oxygenation. This augmentation is afforded 
at low risk, is imple, and avoids distortion of the 
pulmonary arteries. The results from this and a 
previous eries 9documented a modest improvement 
in arterial oxygen saturation, a drop in hemoglobin 
level, and a substantial improvement in effort toler- 
ance. Follow-up data from this review suggest that 
most shunts remain patent for many years and do 
not require anticoagulation. 
This approach to augmenting earlier palliation 
should be considered in any patient who requires 
improved oxygen saturation and is not considered a 
candidate for further, more definitive correction. 
Importantly, this small left-to-right shunt did not 
cause volume overload of the ventricular chamber, 
and no patient had symptoms of congestive heart 
failure. 
The prevalence of pulmonary AV fistulas in the 
ipsilateral lung after Glenn anastomosis may be as 
high as 19.7%. 9 This could preclude many patients 
from undergoing creation of an axillary AV fistula 
because it is believed that the increased flow would 
bypass alveoli for oxygen exchange and place vol- 
urne load on the heart. Several theories have been 
proposed to explain the development of such pul- 
monary fistulas; these include nonpulsatile flow 
characteristics through the shunt 1°' 12 and the influ- 
ence of an as yet unknown hepatic factor. Such 
fistulas appear to occur only in patients who do not 
have any source of hepatic venous blood flow to the 
lungs, as with a Glenn anastomosis or bidirectional 
cavopulmonary connection with ligation or atresia 
of the main pulmonary artery. Pulmonary fistulas 
have not been reported in midterm to long-term 
follow-up after the Fontan procedure with inferior 
vena caval blood entering the pulmonary arteries, a2 
but they have been observed when there is a Glenn 
shunt in the circuit and have been reported fre- 
quently after the Kawashima procedure (total caval 
diversion to the pulmonary arteries with hepatic 
veins draining into the heart). 13 In the only two 
reported cases of pulmonary AV malformations 
after a modified Fontan procedure, it is of interest 
that hepatic venous blood was not conducted to one 
or both pulmonary arteries. 14 Recent reports also 
link the presence of pulmonary AV malfoimations 
to left atrial isomerism with no other cardiac lesion 
and without evidence of hereditary telangiecta- 
sia.~». 10 It has been speculated that this may repre- 
sent a problem with embryogenesis. 
Systemic arterial flow from an axillary fistula 
could contribute to the prevention of pulmonary AV 
fistulas by adding pulsatility to the circuit or possibly 
by allowing the removal or addition of an unknown 
vasoactive hepatic substance. ~7An interesting cor- 
ollary is the hepatopulmonary syndrome, in which 
pulmonary AV fistulas develop in the presence of 
severe hepatic failure, is which may regress after 
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allograft liver transplantation. 19 It is interesting to 
note that none of the patients who have undergone 
a cavopulmonary shunt and axillary fistula cuation 
had pulmonary AV malformations in the ipsilateral 
lung during the 7.4 years of follow-up, after having 
had the initial Glenn shunt for a total average of 6.4 
years, a period when such patients are at greatest 
risk for the development of pulmonary AV fistulas. 7
Although the failure of pulmonary AV malforma- 
tions to develop in this series is not definitive proof 
that the axillary fistula is protective, the addition of 
such systemic arterial flow to either a Glenn or 
bidirectional cavopulmonary connection may reduce 
the tendency toward development of pulmonary 
fistulas or perhaps allow their resolution. 
We thank Dr. Michael Black, Fellow in Cardiovascular 
Surgery, for the diagram of the operative technique 
employed in the creation of axillary arteriovenous fi tulas. 
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